Q1 2021 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2021-06-04 | ||||||
REV |
Q4 2020 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2021-03-19 | ||||||
REV |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
Ticker | Company | Price | Change | Chg % | Mkt Cap | |
---|---|---|---|---|---|---|
FHTX | Foghorn Therapeutics | 13.71 | -0.98 | -6.67% | 504.1M |
You can purchase shares of Foghorn Therapeutics (NASDAQ: FHTX) through any online brokerage.
There are no as such competitors for Foghorn Therapeutics.
The latest price target for Foghorn Therapeutics (NASDAQ: FHTX) was reported by Wedbush on 2020-11-17. The analyst firm set a price target for 24.00 expecting FHTX to rise to within 12 months (a possible 75.05% upside). 4 analyst firms have reported ratings in the last year.
The stock price for Foghorn Therapeutics (NASDAQ: FHTX) is $13.71 last updated Fri Mar 05 2021 21:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Foghorn Therapeutics.
There is no upcoming split for Foghorn Therapeutics.